| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7220247 | TERSERA | Automatically operable safety shield system for syringes |
Apr, 2022
(1 year, 5 months ago) | |
| US7118552 | TERSERA | Automatically operable safety shield system for syringes |
Apr, 2022
(1 year, 5 months ago) | |
Zoladex is owned by Tersera.
Zoladex contains Goserelin Acetate.
Zoladex has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Zoladex are:
- US7220247
- US7118552
Zoladex was authorised for market use on 29 December, 1989.
Zoladex is available in implant;implantation dosage forms.
The generics of Zoladex are possible to be released after 13 April, 2022.
Drugs and Companies using GOSERELIN ACETATE ingredient
Market Authorisation Date: 29 December, 1989
Treatment: NA
Dosage: IMPLANT;IMPLANTATION
More Information on Dosage
ZOLADEX family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic